# Strategy of Surgical Resection With Adjuvant Therapy for IIIA NSCLC and N2 Disease Only in Subaortic or Paraaortic Level

> **NCT02555592** · — · UNKNOWN · sponsor: **Pusan National University Hospital** · enrollment: 25 (estimated)

## Conditions studied

- Lung Cancer
- Cancer of Lymph Node
- Effects of Chemotherapy
- Surgery

## Interventions

- **PROCEDURE:** Primary surgical resection with sequential adjuvant therapy

## Key facts

- **NCT ID:** NCT02555592
- **Lead sponsor:** Pusan National University Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-10
- **Primary completion:** 2021-12
- **Final completion:** 2021-12
- **Target enrollment:** 25 (ESTIMATED)
- **Last updated:** 2015-10-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02555592

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02555592, "Strategy of Surgical Resection With Adjuvant Therapy for IIIA NSCLC and N2 Disease Only in Subaortic or Paraaortic Level". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02555592. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*